Bright Minds Biosciences, Inc. (DRUG)
20.75
+1.79
(+9.44%)
USD |
NASDAQ |
Nov 05, 16:00
20.76
+0.01
(+0.05%)
After-Hours: 20:00
Bright Minds Biosciences Price : 20.75 for Nov. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2026 | 22.10 | 22.48 | 18.10 | 18.96 | 500359.0 |
| Nov 03, 2026 | 25.07 | 26.69 | 21.09 | 21.55 | 995459.0 |
| Nov 02, 2026 | 29.20 | 29.94 | 18.90 | 26.20 | 1.827M |
| Oct 30, 2026 | 56.90 | 57.00 | 54.96 | 54.98 | 95820.00 |
| Oct 29, 2026 | 56.35 | 57.79 | 55.84 | 56.69 | 67541.00 |
| Oct 28, 2026 | 54.25 | 56.13 | 53.65 | 55.32 | 71096.00 |
| Oct 27, 2026 | 51.17 | 54.83 | 49.89 | 54.02 | 59413.00 |
| Oct 26, 2026 | 52.72 | 53.46 | 50.29 | 51.09 | 89060.00 |
| Oct 23, 2026 | 51.77 | 52.65 | 51.00 | 52.48 | 59192.00 |
| Oct 22, 2026 | 50.44 | 53.10 | 49.92 | 52.69 | 221305.0 |
| Oct 21, 2026 | 55.34 | 59.71 | 49.80 | 50.44 | 156372.0 |
| Oct 20, 2026 | 54.00 | 57.50 | 54.00 | 55.20 | 94698.00 |
| Oct 19, 2026 | 53.07 | 54.27 | 49.87 | 53.82 | 156325.0 |
| Oct 16, 2026 | 54.15 | 54.15 | 51.30 | 51.30 | 56035.00 |
| Oct 15, 2026 | 51.80 | 55.75 | 51.24 | 54.21 | 121463.0 |
| Oct 14, 2026 | 50.52 | 52.96 | 49.06 | 50.71 | 199356.0 |
| Oct 13, 2026 | 54.01 | 54.35 | 50.99 | 51.36 | 246572.0 |
| Oct 12, 2026 | 53.89 | 55.20 | 53.27 | 54.01 | 134583.0 |
| Oct 09, 2026 | 52.45 | 55.78 | 51.91 | 54.05 | 98415.00 |
| Oct 08, 2026 | 51.01 | 52.64 | 49.29 | 52.00 | 67926.00 |
| Oct 07, 2026 | 47.23 | 53.01 | 47.23 | 52.00 | 688820.0 |
| Oct 06, 2026 | 49.79 | 50.00 | 47.60 | 48.25 | 107660.0 |
| Oct 05, 2026 | 50.69 | 51.34 | 49.08 | 49.79 | 55951.00 |
| Oct 02, 2026 | 49.61 | 51.04 | 48.75 | 50.69 | 154901.0 |
| Oct 01, 2026 | 49.54 | 52.12 | 48.53 | 49.21 | 166987.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 460.35 |
| Lineage Cell Therapeutics, Inc. | 0.9824 |
| Recursion Pharmaceuticals, Inc. | 3.49 |
| Agenus, Inc. | 6.42 |
| Anika Therapeutics, Inc. | 19.30 |
Price Related Metrics
| PEG Ratio | -0.0828 |
| Price to Book Value | 0.9435 |
| Earnings Yield | -10.04% |
| Market Cap | 204.68M |
| PEGY Ratio | -0.0828 |